Mary E. Klotman insider trades

Open-market stock purchases and sales by Mary E. Klotman, Director at Amgen Inc, from SEC Form 4 filings since May 31, 2024.

Recent trades

DateStockTradeValue
May 19, 2026AMGN Amgen IncBought (not open market)—

Companies traded

  • AMGN Amgen Inc: other filings, last May 19, 2026

Get free alerts when Mary E. Klotman files a new trade →